Leukotriene D4

One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)

Also Known As:

Leukotriene D; Leukotriene D-4; Leukotrienes D; Leukotriene D 4; LTD4; Glycine, N- (S- (1- (4- carboxy- 1- hydroxybutyl)- 2,4,6,9- pentadecatetraenyl)- L- cysteinyl)- , (R-(R*,S*-(E,E,Z,Z)))-

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Arachidonic Acids: 122
        Leukotrienes: 4095
        SRS-A: 186
        Leukotriene D4: 512
    - Essential Fatty Acids: 734
      - Arachidonic Acids: 122
        Leukotrienes: 4095
        SRS-A: 186
        Leukotriene D4: 512
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Eicosanoids: 3262
      - Leukotrienes: 4095
        SRS-A: 186
        Leukotriene D4: 512

iodinated azido-leukotriene D4

Bio-Agent Context: Research Results